Clinical trial
Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins
NCT00377806 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00377806 |
|---|---|
| Title | Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins |
| Official title | A One Week, Double-Blind, Adaptive, Randomized, Multicenter Study to Compare the Efficacy, Safety and Tolerability of Topical Diclofenac Gel Versus Placebo in Patients With Superficial Thrombophlebitis |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Superficial Thrombophlebitis of the Upper Limb |
| Intervention type | Drug |
| Interventions | Diclofenac gel |
| Enrollment | 200 |
| Start date | Jan 1, 2003 |
| Completion | Sep 1, 2006 |
| First posted | Sep 18, 2006 |
| Last update posted | Dec 10, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: